Entry Point Capital, LLC Vericel Corp Transaction History
Entry Point Capital, LLC
- $246 Million
- Q3 2025
A detailed history of Entry Point Capital, LLC transactions in Vericel Corp stock. As of the latest transaction made, Entry Point Capital, LLC holds 8,413 shares of VCEL stock, worth $335,342. This represents 0.11% of its overall portfolio holdings.
Number of Shares
8,413
Previous 10,559
20.32%
Holding current value
$335,342
Previous $449,000
41.2%
% of portfolio
0.11%
Previous 0.24%
Shares
5 transactions
Others Institutions Holding VCEL
# of Institutions
275Shares Held
52.6MCall Options Held
36.6KPut Options Held
9.1K-
Black Rock Inc. New York, NY8.06MShares$321 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.52MShares$140 Million0.0% of portfolio
-
State Street Corp Boston, MA2.81MShares$112 Million0.0% of portfolio
-
William Blair Investment Management, LLC Chicago, IL2.21MShares$88.1 Million0.19% of portfolio
-
Conestoga Capital Advisors, LLC2.18MShares$86.7 Million1.1% of portfolio
About Vericel Corp
- Ticker VCEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,178,000
- Market Cap $1.88B
- Description
- Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...